Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis: Results from The Danbio Registry

B. Glintborg, I. J. Sørensen, D. Vendelbo Jensen, N. S. Krogh, A. G. Loft, A. Colic, J. Espesen, J. Olsen, O. Hendricks, J Grydehøj, I. M. J. Hansen, M. V. Sørensen, S. Chrysidis, N. Manilo, M. Klarlund, L. S. Andersen, H. Nordin, S. Kristensen, M. L. Hetland

Original languageEnglish
Article numberOP0225
JournalAnnals of the Rheumatic Diseases
Volume75
Issue numberSuppl 2
Number of pages1
ISSN0003-4967
DOIs
Publication statusPublished - 2016

Cite this